Cargando…

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia

Platelet transfusion is important in the prevention and treatment of bleeding in patients with acute myeloid leukemia (AML) after receiving intensive chemotherapy. However, platelet transfusion refractoriness (PTR) is an intractable clinical issue occurred in these patients. And its clinical and imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xuelian, Cai, Haodong, Zheng, Lu, Luo, Yi, Zhou, Jing, Hui, Yan, Dai, Zhenyu, Lin, Haolong, Li, Dengju, Xiao, Yi, Huang, Liang, Zhou, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367618/ https://www.ncbi.nlm.nih.gov/pubmed/32419364 http://dx.doi.org/10.1002/cam4.3140

Ejemplares similares

Extent of transfusion support in a developing country in managing a bleeding acute myeloid leukemia patient with platelet transfusion refractoriness
por: Chellaiya, Gayathiri K., et al.
Publicado: (2021)

DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
por: Sun, Guo‐Kang, et al.
Publicado: (2019)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
por: Goswami, Meghali, et al.
Publicado: (2022)

A case of platelet transfusion refractoriness in a CD36‐negative patient with acute myeloid leukemia: Diagnostic and therapeutic management
por: Pedini, Pascal, et al.
Publicado: (2022)

Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients
por: Zhang, Jing-Cheng, et al.
Publicado: (2023)

Evaluation and management of platelet transfusion refractoriness
por: Youk, Hee-Jeong, et al.
Publicado: (2022)

Changes in inflammatory responses and autophagy during apheresis platelet preservation and their correlation with platelet transfusion refractoriness in patients with acute lymphoblastic leukemia
por: Li, Ying, et al.
Publicado: (2023)

Overexpression of PRDM5 promotes acute myeloid leukemia cell proliferation and migration by activating the JNK pathway
por: Zhou, Pan, et al.
Publicado: (2019)

Platelet Transfusion – The New Immunology of an Old Therapy
por: Stolla, Moritz, et al.
Publicado: (2015)

Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies.
por: Lee, M., et al.
Publicado: (1988)

Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusions
por: Agarwal, Nitin, et al.
Publicado: (2014)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re‐induction chemotherapy
por: Ruan, Min, et al.
Publicado: (2021)

First platelet transfusion refractoriness in a patient with acute myelocytic leukemia: A case report
por: Tu, Sheng-Ke, et al.
Publicado: (2023)

Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion
por: Belizaire, Roger, et al.
Publicado: (2020)

Restoration of ceramide de novo synthesis by the synthetic retinoid ST1926 as it induces adult T-cell leukemia cell death
por: Ghandour, Botheina, et al.
Publicado: (2020)

Circulating CD14(+) HLA‐DR (‐/low) myeloid‐derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft‐versus‐host disease
por: Yin, Jin, et al.
Publicado: (2016)

Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia
por: Zhang, Qianying, et al.
Publicado: (2017)

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Liu, Yadan, et al.
Publicado: (2021)

Rates of complete diagnostic testing for patients with acute myeloid leukemia
por: Lin, Tara L, et al.
Publicado: (2015)

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023)

Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion
por: Garraud, Olivier, et al.
Publicado: (2019)

Inhibition of NEDD8 NEDDylation induced apoptosis in acute myeloid leukemia cells via p53 signaling pathway
por: Chen, Yanli, et al.
Publicado: (2022)

Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
por: Nan, Fang‐yu, et al.
Publicado: (2021)

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia
por: Cheng, Jiali, et al.
Publicado: (2023)

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
por: Gill, Harinder, et al.
Publicado: (2020)

B7‐H3 protein expression in acute myeloid leukemia
por: Guery, Thomas, et al.
Publicado: (2015)

Characterizing the Molecular Abnormalities in Rare De Novo Ph(+) Acute Myeloid Leukemia
por: Chao, Hong-Ying, et al.
Publicado: (2018)

Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia
por: Faisal, Muhammad, et al.
Publicado: (2019)

Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia
por: Zhang, Yujiao, et al.
Publicado: (2023)

The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
por: Liu, Chia‐Jen, et al.
Publicado: (2020)

Increased survival disparities among children and adolescents & young adults with acute myeloid leukemia: A Dutch population‐based study
por: Schulpen, Maya, et al.
Publicado: (2021)

Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group
por: Nagarajan, Rajaram, et al.
Publicado: (2019)

Treatment for Relapsed/Refractory Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2021)

Ectopic expression of human airway trypsin‐like protease 4 in acute myeloid leukemia promotes cancer cell invasion and tumor growth
por: Yan, Ruhong, et al.
Publicado: (2019)

Prognostic and immunological role of Fam20C in pan-cancer
por: Liu, Xinpeng, et al.
Publicado: (2021)

The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation–positive relapsed/refractory acute myeloid leukemia
por: Altman, Jessica K., et al.
Publicado: (2020)

Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis
por: de Botton, Stéphane, et al.
Publicado: (2021)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019)

Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia
por: Takao, Sumiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v2tqibiao1iphc0np7sjqkarqi